KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 85 filers reported holding KALA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 7.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $26,000 | -50.0% | 9,750 | 0.0% | 0.01% | -41.7% |
| Q2 2021 | $52,000 | +44.4% | 9,750 | +80.7% | 0.01% | +50.0% |
| Q1 2021 | $36,000 | -43.8% | 5,397 | -42.7% | 0.01% | -50.0% |
| Q4 2020 | $64,000 | +33.3% | 9,415 | +46.8% | 0.02% | +23.1% |
| Q3 2020 | $48,000 | +6.7% | 6,415 | +50.7% | 0.01% | 0.0% |
| Q2 2020 | $45,000 | -54.5% | 4,256 | -62.2% | 0.01% | -64.9% |
| Q1 2020 | $99,000 | +350.0% | 11,250 | +150.0% | 0.04% | +236.4% |
| Q4 2018 | $22,000 | – | 4,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |